Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 2
1969 1
1970 1
1978 1
1979 2
1981 1
1989 1
1991 2
1995 2
1996 6
1997 1
1998 4
1999 3
2000 4
2001 5
2002 7
2003 7
2004 7
2005 5
2006 10
2007 13
2008 11
2009 11
2010 12
2011 16
2012 11
2013 5
2014 4
2015 11
2016 9
2017 9
2018 6
2019 19
2020 12
2021 5
2022 12
2023 3
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
So könnte die neue GOÄ aussehen!
Frisch J, Höhl R, Nößler D. Frisch J, et al. Among authors: hohl r. MMW Fortschr Med. 2024 Nov;166(19):32-34. doi: 10.1007/s15006-024-4189-4. MMW Fortschr Med. 2024. PMID: 39511085 German. No abstract available.
Ohne Vorteile im Alltag wird die ePA floppen.
Höhl R. Höhl R. MMW Fortschr Med. 2024 Jul;166(12):32. doi: 10.1007/s15006-024-4084-z. MMW Fortschr Med. 2024. PMID: 38995577 German. No abstract available.
So klappen Videosprechstunden bei Ihnen.
Höhl R. Höhl R. MMW Fortschr Med. 2022 Oct;164(18):38-39. doi: 10.1007/s15006-022-1942-4. MMW Fortschr Med. 2022. PMID: 36253695 German. No abstract available.
Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective.
Weissenrieder JS, Neighbors JD, Mailman RB, Hohl RJ. Weissenrieder JS, et al. Among authors: hohl rj. J Pharmacol Exp Ther. 2019 Jul;370(1):111-126. doi: 10.1124/jpet.119.256818. Epub 2019 Apr 18. J Pharmacol Exp Ther. 2019. PMID: 31000578 Free PMC article. Review.
[Pharmacokinetics and pharmacodynamics of antibiotics in intensive care].
Sörgel F, Höhl R, Glaser R, Stelzer C, Munz M, Vormittag M, Kinzig M, Bulitta J, Landersdorfer C, Junger A, Christ M, Wilhelm M, Holzgrabe U. Sörgel F, et al. Among authors: hohl r. Med Klin Intensivmed Notfmed. 2017 Feb;112(1):11-23. doi: 10.1007/s00063-016-0185-5. Epub 2016 Oct 24. Med Klin Intensivmed Notfmed. 2017. PMID: 27778050 Review. German.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Free article. Clinical Trial.
Anti-cancer therapy: targeting the mevalonate pathway.
Swanson KM, Hohl RJ. Swanson KM, et al. Among authors: hohl rj. Curr Cancer Drug Targets. 2006 Feb;6(1):15-37. doi: 10.2174/156800906775471743. Curr Cancer Drug Targets. 2006. PMID: 16475974 Review.
217 results